Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61P - Specific therapeutic activity of chemical compounds or medicinal preparations › A61P 35 - Antineoplastic agents
Patents for A61P 35 - Antineoplastic agents (221,099)
03/2012
03/15/2012CA2810755A1 Substituted imidazopyridazines
03/15/2012CA2810636A1 Ttll4 peptides and vaccines containing the same
03/15/2012CA2810528A1 Compounds as c-met kinase inhibitors
03/15/2012CA2810499A1 P53-mdm2 antagonists
03/15/2012CA2810359A1 4-1bb binding molecules
03/15/2012CA2809736A1 N-hydroxy-benzamides for the treatment of cancer
03/15/2012CA2714880A1 A novel tumor biomarker
03/14/2012EP2428571A1 MicroRNA molecules
03/14/2012EP2428570A1 MicroRNA molecules
03/14/2012EP2428569A1 MicroRNA molecules
03/14/2012EP2428568A1 MicroRNA molecules
03/14/2012EP2428567A1 MicroRNA molecules
03/14/2012EP2428513A1 5-substituted quinazolinone derivatives as anti-cancer agents
03/14/2012EP2428509A1 Human adam-10 inhibitors
03/14/2012EP2428508A1 Diamino heterocyclic carboxamide compound
03/14/2012EP2428506A1 Heterocyclic substituted acardite derivates and use thereof
03/14/2012EP2428252A1 Neutralization of CD95 activity blocks invasion of glioblastoma cells in vivo
03/14/2012EP2428213A1 Stabilized chlorite solutions in combination with fluoropyrimidines for use in cancer treatment
03/14/2012EP2428211A2 Pharmaceutical composition for preventing or treating neuronal damage and neurological diseases
03/14/2012EP2428203A1 A nano-emulsion injection of vinca alkaloids and the preparation method thereof
03/14/2012EP2427496A1 Anti-vegf-d antibodies
03/14/2012EP2427490A1 Compositions and methods of use for binding molecules to dickkopf-1 or dickkopf-4 or both
03/14/2012EP2427485A2 Cd133 epitopes
03/14/2012EP2427479A2 Antibodies and methods of use thereof
03/14/2012EP2427476A1 Beta-hairpin peptidomimetics having cxcr4 antagonizing activity
03/14/2012EP2427467A1 Triptolide prodrugs
03/14/2012EP2427463A1 Imidazo [1, 2 -a] pyridin-2 -yl-phenyl derivatives to be used in cancer treatment
03/14/2012EP2427462A1 Pyrrolo [2, 3. b]pyridines which inhibit raf protein kinase
03/14/2012EP2427461A1 3-(ý1,2,3¨triazole-4-yl)-pyrroloý2,3-b¨pyridine derivates
03/14/2012EP2427451A1 Alpha helix mimetics and methods relating thereto
03/14/2012EP2427441A1 Pmk2 modulators for use in the treatment of cancer
03/14/2012EP2427433A1 Solid forms of sulfonamides and amino acids
03/14/2012EP2427216A2 Uses of immunoconjugates targeting cd138
03/14/2012EP2427213A2 Alpha thymosin peptides as vaccine enhancers
03/14/2012EP2427192A1 Use of osi-906 for treating adrenocortical carcinoma
03/14/2012EP2427188A1 Pyrrolidine-substituted flavones as radio-sensitizers for use in the treatment of cancer
03/14/2012EP2427187A1 Antitumor combination including cabazitaxel and capecitabine
03/14/2012EP2427185A1 Antitumor combination including ave8062 and sorafenib
03/14/2012EP2427183A2 Therapeutic compounds
03/14/2012EP2427176A1 Polymer micelles containing sn-38 for the treatment of cancer
03/14/2012EP2427057A1 Benzofuran-4,5-diones as selective peptide deformylase inhibitors
03/14/2012EP2187741B1 Novel forms of cddo methyl ester
03/14/2012EP2152714B1 SPIROINDOLINONE DERIVATIVES AS MDM2-p53 INHIBITORS
03/14/2012EP2078018B1 Heteroaryl compounds, compositions thereof, and use thereof as protein kinase inhibitors
03/14/2012EP2029600B1 Substituted pteridines substituted with a four-membered heterocycle
03/14/2012EP1968592B1 Formulations comprising jorumycin-, renieramycin-, safracin- or saframycin-related compounds and a disaccharide for treating proliferative diseases
03/14/2012EP1928872B1 Novel sulphonylpyrroles as inhibitors of hdac
03/14/2012EP1613658B1 Antibodies against insulin-like growth factor i receptor and uses thereof
03/14/2012EP1546194B1 Therapeutic uspa1-derived peptides
03/14/2012EP1499729B9 Derivatives of the nf-kappab inducing enzyme, their preparation and use
03/14/2012EP1474420B1 Quinazoline compounds
03/14/2012EP1455766B1 Thymosin alpha 1 peptide/polymer conjugates
03/14/2012EP1436003B3 Taci-immunoglobulin fusion proteins
03/14/2012EP1332218B1 Differentiation-inducing substances
03/14/2012CN1976951B Anti-EpCAM immunoglobulins
03/14/2012CN102378761A Pyridine thio derivative, and pharmaceutical composition which contains same and has anti-helicobacter pylori action
03/14/2012CN102378759A Derivatives of 6-(6-o-substituted-triazolopyridazine-sulfanyl) benzothiazoles and benzimidazoles, preparation thereof, use thereof as drugs, and use thereof as met inhibitors
03/14/2012CN102378758A Quinoxaline derivatives and their use for treating benign and malignant tumour disorders
03/14/2012CN102378753A Plasminogen activator inhibitor-1 inhibitor
03/14/2012CN102378633A Immunologic adjuvant composition and use thereof
03/14/2012CN102373232A Novel tissue specific minicircle vector-hIFNgama gene therapeutic drug
03/14/2012CN102373206A PPP2R5C-siRNA799 for targeted inhabitation of PPP2R5C gene expression and tumor T cell multiplication and application thereof
03/14/2012CN102372780A Preparation method and application of anti-human chorionic gonadotropin (hCG) antibody-interleukin 2 (IL2) fusion protein
03/14/2012CN102372779A Camel single domain antibody with allinase activity as well as preparation method and application thereof
03/14/2012CN102372778A Anti-human VEGF/anti-OPN bispecific antibody, its preparation method and application
03/14/2012CN102372773A Human bladder cancer tumor marker, antibody thereof and application thereof
03/14/2012CN102372772A Ruditapes philippin RpTNF gene recombinant protein, its preparation and application
03/14/2012CN102372771A Tumor targeted molecule and application thereof
03/14/2012CN102372770A Angiogenesis inhibitant, purification method and medicinal composition therewith
03/14/2012CN102372741A Zoledronic acid crystal and lyophilized powder injection thereof
03/14/2012CN102372717A Pyrrolopyrimidine compound and use thereof
03/14/2012CN102372716A Phthalazone derivative, its preparation method and application in medicine thereof
03/14/2012CN102372713A Dual alanyl-aminopeptidase and dipeptidyl-peptidase iv inhibitors
03/14/2012CN102372712A Imidazodiazanaphthalene PI3K (phosphatidyl inositol 3 kinase) and mTOR (mammalian target of rapamycin) dual inhibitor
03/14/2012CN102372711A Imidazo quinoline PI3K and mTOR (mammalian target of rapamycin) dual inhibitor
03/14/2012CN102372706A Phthalazinone derivative, its preparation method and application in medicament
03/14/2012CN102372698A Phthalazinone derivative and its preparation method and use in medicine
03/14/2012CN102372630A Resorcinol derivative with antitumor activity, its preparation method and application
03/14/2012CN102370992A Novel cis-platinum nano biodegradable medicinal composition and preparation method
03/14/2012CN102370988A Technology for transferring antitumor medicament with single-wall carbon nanotube and application thereof
03/14/2012CN102370987A Injection liposome entrapping antineoplastic pharmaceutical composition
03/14/2012CN102370986A Pharmaceutical compositions containing hydroxymethyl neurosedyn derivatives as well as preparation and application thereof
03/14/2012CN102370983A Anti-tumor medicine composition and purpose thereof
03/14/2012CN102370980A Preparation method of nanometer graphene oxide carrier for photodynamic therapy
03/14/2012CN102370979A Building method for autovaccine by aiming at human TNF(Tumor Necrosis Factor)-alpha molecule
03/14/2012CN102370974A Yeast-based vaccines as immunotherapy
03/14/2012CN102370967A Novel application of IL-1Ra (interleukin-1 receptor antagonist) and tumor treatment medicinal composition kit thereof
03/14/2012CN102370953A Pure Chinese medicinal herb preparation for treating cancer pain and postoperative pain and preparation method thereof
03/14/2012CN102370939A Body resistance-strengthening and anticancer traditional Chinese medicine
03/14/2012CN102370919A Medicinal combination for eliminating blood stasis and softening hardness and preparation method thereof
03/14/2012CN102370912A Medicine for treating tumors
03/14/2012CN102370905A Application of hemopoietic pill in preparation of medicine for preventing or repairing cell damage caused by environmental pollutions
03/14/2012CN102370886A Traditional Chinese medicinal composition for resisting breast cancer metastasis
03/14/2012CN102370851A Chinese herbal medicine for treating hysteromyoma and regulating menstruation
03/14/2012CN102370801A Medicine for treating stomach cancers
03/14/2012CN102370758A Antitumor traditional Chinese medicine
03/14/2012CN102370756A Chinese patent drug and Chinese medicine decoction capable of effectively curing intestinal cancer, liver cancer, uterine cancer and stomach cancer
03/14/2012CN102370716A Health-preserving health-care medicine of gynostemma pentaphylla and multiflower knotweed root
03/14/2012CN102370695A Qinglongyi active extract, its preparation method and its application
03/14/2012CN102370647A Application of dexrazoxane as antioxidant
1 ... 377 378 379 380 381 382 383 384 385 386 387 388 389 390 391 392 393 394 395 396 397 ... 2211